Search research articles
Contact Us
Filters
Showing results (181-190 of 291) with videos related to
Page
of 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics
Dhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Cancer Immunology Research
|
March 24, 2019
Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
Amy K Kim, Faiz Gani, Andrew J Layman, et al.
Clinical & Experimental Metastasis
|
May 8, 2024
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer
Aaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Biorxiv : the Preprint Server for Biology
|
February 14, 2024
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2<sup>+</sup> breast cancer
Aaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F Shields, Paula M Jacobs, Mario Sznol, et al.
Current Problems in Cancer
|
October 26, 2002
Pancreatic cancer
Theresa Pluth Yeo, Ralph H Hruban, Steven D Leach, et al.
Clinical Epigenetics
|
February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
Katherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Bioinformatics (Oxford, England)
|
October 15, 2025
BIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells
Daniel R Bergman, Jeanette A I Johnson, Marwa Naji, et al.
Cancer Research Communications
|
October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors
Theron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Hepatology (Baltimore, Md.)
|
December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma
Daniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Page
of 30
Search research articles
Search
Showing results (181-190 of 291) with videos related to
Sort By:
Page
of 30
Proceedings of the National Academy of Sciences of the United States of America
|
September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics
Dhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Cancer Immunology Research
|
March 24, 2019
Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
Amy K Kim, Faiz Gani, Andrew J Layman, et al.
Clinical & Experimental Metastasis
|
May 8, 2024
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer
Aaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Biorxiv : the Preprint Server for Biology
|
February 14, 2024
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2<sup>+</sup> breast cancer
Aaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F Shields, Paula M Jacobs, Mario Sznol, et al.
Current Problems in Cancer
|
October 26, 2002
Pancreatic cancer
Theresa Pluth Yeo, Ralph H Hruban, Steven D Leach, et al.
Clinical Epigenetics
|
February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
Katherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Bioinformatics (Oxford, England)
|
October 15, 2025
BIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells
Daniel R Bergman, Jeanette A I Johnson, Marwa Naji, et al.
Cancer Research Communications
|
October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors
Theron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Hepatology (Baltimore, Md.)
|
December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma
Daniel J Zabransky, Emma Kartalia, Jae W Lee, et al.
Page
of 30